AAPL351.63+9.26 (+2.70%) ▲|ABBV292.69+1.38 (+0.47%) ▲|ABT110.48+0.55 (+0.50%) ▲|ACN255.33-5.17 (-1.98%) ▼|ADBE237.28-2.03 (-0.85%) ▼|AMAT374.09+41.38 (+12.44%) ▲|AMD512.92+63.88 (+14.23%) ▲|AMGN464.40+3.98 (+0.86%) ▲|AMT189.45+0.66 (+0.35%) ▲|AMZN268.80+9.50 (+3.66%) ▲|AVGO322.24+28.55 (+9.72%) ▲|AXP325.49+4.50 (+1.40%) ▲|BA173.77+0.37 (+0.21%) ▲|BAC50.87+1.45 (+2.92%) ▲|BKNG163.56+2.90 (+1.80%) ▲|BLK1,223.18+44.31 (+3.76%) ▲|BMY62.44+0.30 (+0.48%) ▲|BNY151.65+3.93 (+2.66%) ▲|BRK-B577.33+6.44 (+1.13%) ▲|C122.25+3.20 (+2.69%) ▲|CAT597.80+39.17 (+7.01%) ▲|CL97.89+1.33 (+1.38%) ▲|CMCSA24.46+0.07 (+0.27%) ▲|COF199.58-2.30 (-1.14%) ▼|COP134.33-1.94 (-1.43%) ▼|COST1,061.71+8.15 (+0.77%) ▲|CRM215.33+1.68 (+0.78%) ▲|CSCO99.26+5.41 (+5.76%) ▲|CVS84.49+0.64 (+0.76%) ▲|CVX210.18-2.43 (-1.14%) ▼|DE695.14+23.49 (+3.50%) ▲|DHR236.17+5.92 (+2.57%) ▲|DIS119.18+2.43 (+2.08%) ▲|DUK128.99+1.21 (+0.95%) ▲|EMR171.54+9.19 (+5.66%) ▲|FDX320.39+12.25 (+3.97%) ▲|GD363.10+9.04 (+2.55%) ▲|GE337.15+13.91 (+4.30%) ▲|GEV836.34+62.23 (+8.04%) ▲|GILD169.74+2.85 (+1.71%) ▲|GM89.90+3.74 (+4.34%) ▲|GOOG287.61+3.68 (+1.30%) ▲|GOOGL289.53+4.75 (+1.67%) ▲|GS909.32+43.50 (+5.02%) ▲|HD356.01+12.54 (+3.65%) ▲|HON229.68+9.63 (+4.38%) ▲|IBM248.63+3.63 (+1.48%) ▲|INTC59.41+3.13 (+5.56%) ▲|INTU337.94-3.56 (-1.04%) ▼|ISRG461.52+8.72 (+1.93%) ▲|JNJ282.27+6.05 (+2.19%) ▲|JPM342.73+8.24 (+2.46%) ▲|KO95.78+0.11 (+0.11%) ▲|LIN522.92+7.67 (+1.49%) ▲|LLY1,418.19+64.19 (+4.74%) ▲|LMT588.14+21.06 (+3.71%) ▲|LOW233.64+9.09 (+4.05%) ▲|LRCX221.58+21.14 (+10.55%) ▲|MA658.62+5.92 (+0.91%) ▲|MCD282.33+5.81 (+2.10%) ▲|MDLZ66.49+0.47 (+0.70%) ▲|MDT103.29+1.49 (+1.46%) ▲|META646.67+36.52 (+5.99%) ▲|MMM190.02+4.87 (+2.63%) ▲|MO75.76-0.36 (-0.47%) ▼|MRK148.12+1.39 (+0.95%) ▲|MS187.68+6.24 (+3.44%) ▲|MSFT547.77+17.16 (+3.23%) ▲|MU739.61+49.61 (+7.19%) ▲|NEE87.19+0.24 (+0.27%) ▲|NFLX63.74+0.33 (+0.51%) ▲|NKE40.07+1.48 (+3.82%) ▲|NOW103.52+1.55 (+1.52%) ▲|NVDA178.11-8.54 (-4.57%) ▼|ORCL119.85+3.75 (+3.23%) ▲|PEP142.31+0.97 (+0.69%) ▲|PFE29.42+0.03 (+0.09%) ▲|PG168.55+3.15 (+1.90%) ▲|PLTR170.42+10.04 (+6.26%) ▲|PM193.24-4.64 (-2.34%) ▼|QCOM172.34+6.93 (+4.19%) ▲|RTX196.82+7.29 (+3.85%) ▲|SBUX110.06+4.65 (+4.41%) ▲|SCHW93.23+1.74 (+1.90%) ▲|SO93.80+1.46 (+1.58%) ▲|SPG233.06+4.64 (+2.03%) ▲|T21.65+0.02 (+0.07%) ▲|TMO720.46+25.70 (+3.70%) ▲|TMUS168.60+6.59 (+4.07%) ▲|TSLA381.00+22.78 (+6.36%) ▲|TXN295.80+18.44 (+6.65%) ▲|UBER71.06+2.47 (+3.60%) ▲|UNH396.99+2.84 (+0.72%) ▲|UNP296.64+6.48 (+2.23%) ▲|UPS111.69+3.39 (+3.13%) ▲|USB61.15+1.70 (+2.85%) ▲|V422.36-0.30 (-0.07%) ▼|VZ45.95+0.26 (+0.56%) ▲|WFC85.80+1.86 (+2.22%) ▲|WMT125.63+0.11 (+0.09%) ▲|XOM164.47-1.41 (-0.85%) ▼|AAPL351.63+9.26 (+2.70%) ▲|ABBV292.69+1.38 (+0.47%) ▲|ABT110.48+0.55 (+0.50%) ▲|ACN255.33-5.17 (-1.98%) ▼|ADBE237.28-2.03 (-0.85%) ▼|AMAT374.09+41.38 (+12.44%) ▲|AMD512.92+63.88 (+14.23%) ▲|AMGN464.40+3.98 (+0.86%) ▲|AMT189.45+0.66 (+0.35%) ▲|AMZN268.80+9.50 (+3.66%) ▲|AVGO322.24+28.55 (+9.72%) ▲|AXP325.49+4.50 (+1.40%) ▲|BA173.77+0.37 (+0.21%) ▲|BAC50.87+1.45 (+2.92%) ▲|BKNG163.56+2.90 (+1.80%) ▲|BLK1,223.18+44.31 (+3.76%) ▲|BMY62.44+0.30 (+0.48%) ▲|BNY151.65+3.93 (+2.66%) ▲|BRK-B577.33+6.44 (+1.13%) ▲|C122.25+3.20 (+2.69%) ▲|CAT597.80+39.17 (+7.01%) ▲|CL97.89+1.33 (+1.38%) ▲|CMCSA24.46+0.07 (+0.27%) ▲|COF199.58-2.30 (-1.14%) ▼|COP134.33-1.94 (-1.43%) ▼|COST1,061.71+8.15 (+0.77%) ▲|CRM215.33+1.68 (+0.78%) ▲|CSCO99.26+5.41 (+5.76%) ▲|CVS84.49+0.64 (+0.76%) ▲|CVX210.18-2.43 (-1.14%) ▼|DE695.14+23.49 (+3.50%) ▲|DHR236.17+5.92 (+2.57%) ▲|DIS119.18+2.43 (+2.08%) ▲|DUK128.99+1.21 (+0.95%) ▲|EMR171.54+9.19 (+5.66%) ▲|FDX320.39+12.25 (+3.97%) ▲|GD363.10+9.04 (+2.55%) ▲|GE337.15+13.91 (+4.30%) ▲|GEV836.34+62.23 (+8.04%) ▲|GILD169.74+2.85 (+1.71%) ▲|GM89.90+3.74 (+4.34%) ▲|GOOG287.61+3.68 (+1.30%) ▲|GOOGL289.53+4.75 (+1.67%) ▲|GS909.32+43.50 (+5.02%) ▲|HD356.01+12.54 (+3.65%) ▲|HON229.68+9.63 (+4.38%) ▲|IBM248.63+3.63 (+1.48%) ▲|INTC59.41+3.13 (+5.56%) ▲|INTU337.94-3.56 (-1.04%) ▼|ISRG461.52+8.72 (+1.93%) ▲|JNJ282.27+6.05 (+2.19%) ▲|JPM342.73+8.24 (+2.46%) ▲|KO95.78+0.11 (+0.11%) ▲|LIN522.92+7.67 (+1.49%) ▲|LLY1,418.19+64.19 (+4.74%) ▲|LMT588.14+21.06 (+3.71%) ▲|LOW233.64+9.09 (+4.05%) ▲|LRCX221.58+21.14 (+10.55%) ▲|MA658.62+5.92 (+0.91%) ▲|MCD282.33+5.81 (+2.10%) ▲|MDLZ66.49+0.47 (+0.70%) ▲|MDT103.29+1.49 (+1.46%) ▲|META646.67+36.52 (+5.99%) ▲|MMM190.02+4.87 (+2.63%) ▲|MO75.76-0.36 (-0.47%) ▼|MRK148.12+1.39 (+0.95%) ▲|MS187.68+6.24 (+3.44%) ▲|MSFT547.77+17.16 (+3.23%) ▲|MU739.61+49.61 (+7.19%) ▲|NEE87.19+0.24 (+0.27%) ▲|NFLX63.74+0.33 (+0.51%) ▲|NKE40.07+1.48 (+3.82%) ▲|NOW103.52+1.55 (+1.52%) ▲|NVDA178.11-8.54 (-4.57%) ▼|ORCL119.85+3.75 (+3.23%) ▲|PEP142.31+0.97 (+0.69%) ▲|PFE29.42+0.03 (+0.09%) ▲|PG168.55+3.15 (+1.90%) ▲|PLTR170.42+10.04 (+6.26%) ▲|PM193.24-4.64 (-2.34%) ▼|QCOM172.34+6.93 (+4.19%) ▲|RTX196.82+7.29 (+3.85%) ▲|SBUX110.06+4.65 (+4.41%) ▲|SCHW93.23+1.74 (+1.90%) ▲|SO93.80+1.46 (+1.58%) ▲|SPG233.06+4.64 (+2.03%) ▲|T21.65+0.02 (+0.07%) ▲|TMO720.46+25.70 (+3.70%) ▲|TMUS168.60+6.59 (+4.07%) ▲|TSLA381.00+22.78 (+6.36%) ▲|TXN295.80+18.44 (+6.65%) ▲|UBER71.06+2.47 (+3.60%) ▲|UNH396.99+2.84 (+0.72%) ▲|UNP296.64+6.48 (+2.23%) ▲|UPS111.69+3.39 (+3.13%) ▲|USB61.15+1.70 (+2.85%) ▲|V422.36-0.30 (-0.07%) ▼|VZ45.95+0.26 (+0.56%) ▲|WFC85.80+1.86 (+2.22%) ▲|WMT125.63+0.11 (+0.09%) ▲|XOM164.47-1.41 (-0.85%) ▼|
13.7 C
New York
Monday, November 9, 2026

Tag: company

newsFORsourcecompanycontentinformationreleases1IT

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OGN

NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (the “Class Period”), of the important July 22, 2025 lead plaintiff deadline.

IOVA INVESTOR NEWS: Iovance Biotherapeutics, Inc. has been Sued for Securities Fraud – Contact BFA Law before July 14 Deadline (NASDAQ:IOVA)

Iovance Biotherapeutics, Inc. investors that lost money are notified to contact BFA Law before July 14, 2025 securities fraud class action deadline.

FTRE INVESTOR NEWS: Fortrea Holdings Inc. has been Sued for Securities Fraud – Contact BFA Law before August 1 Deadline (NASDAQ:FTRE)

Fortrea Holdings Inc. investors that lost money are notified to contact BFA Law before August 1, 2025 securities fraud class action deadline.

OGN INVESTOR NEWS: Organon & Co. has been Sued for Securities Fraud – Contact BFA Law before July 22 Deadline (NYSE:OGN)

Organon & Co. investors that lost money are notified to contact BFA Law before July 22, 2025 securities fraud class action deadline.

CODI INVESTOR NEWS: Compass Diversified Holdings has been Sued for Securities Fraud – Contact BFA Law before July 8 Deadline (NYSE:CODI)

Compass Diversified Holdings investors that lost money are notified to contact BFA Law before July 8, 2025 securities fraud class action deadline.

ELV INVESTOR NEWS: Elevance Health, Inc. has been Sued for Securities Fraud – Contact BFA Law before July 11 Deadline (NYSE:ELV)

Elevance Health, Inc. investors that lost money are notified to contact BFA Law before July 11, 2025 securities fraud class action deadline.

CIVI INVESTOR NEWS: Civitas Resources, Inc. has been Sued for Securities Fraud – Contact BFA Law before July 1 Deadline (NYSE:CIVI)

Civitas Resources, Inc. investors that lost money are notified to contact BFA Law before July 1, 2025 securities fraud class action deadline.

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages NET Power Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NPWR,...

NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NET Power Inc. (NYSE: NPWR, NPWR.WS) between June 9, 2023 and March 7, 2025, both dates inclusive (the “Class Period”), of the important June 17, 2025 lead plaintiff deadline.

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline.

NAVER Expands Startup Investments in Silicon Valley with the Planned Establishment of NAVER Ventures

- Key executives, including Founder Lee Hae-jin and CEO Choi Soo-yeon, engage in discussions with the local startup ecosystem- The new investment initiative will...

Dupixent® (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color

TEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 07, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tempus AI, Inc. (NASDAQ: TEM) resulting from allegations that Tempus AI may have issued materially misleading business information to the investing public.

Popit Games Tournament Early Access Launches June 7th with $500,000+ Prize Pool

Mobile Gaming Tournament Opens to Players Worldwide via Steam and Android SOFIA, Bulgaria, June 7, 2025 /PRNewswire/ -- Acki Nacki, the fastest blockchain possible, today...

Ro Weight Loss Announces Official Website Update Featuring Natural Daily Program for Medically-Guided Weight Management

Digital health platform offers FDA-approved treatments when appropriate and personalized care plans through licensed providers. 
Digital health platform offers FDA-approved treatments when appropriate and personalized care plans through licensed providers.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompany

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers